Notably, pharmacological inhibition of CRMP2 hyperphosphorylation using (S)-LCM [20] mitigated PTP induction, revealing a previously unrecognized mechanism of PTP regulation in AD mitochondria. Here, DPYSL2 is linked to Alzheimer disease.